Inhibition of human UDP-glucuronosyltransferase enzymes by lapatinib, pazopanib, regorafenib and sorafenib: Implications for hyperbilirubinemia

John O. Miners, Nuy Chau, Andrew Rowland, Kushari Burns, Ross A. McKinnon, Peter I. Mackenzie, Geoffrey T. Tucker, Kathleen Knights, Ganessan Kichenadasse

Biochemical Pharmacology · 2017 · 83 citations · 38 references

Concepts

References

38